康泰生物：控股股东杜兴连拟减持不超过0.24%

Core Viewpoint - The company announced that its controlling shareholder, Du Xinglian, plans to reduce his holdings by up to 2.724 million shares, representing 0.24% of the total share capital, due to personal financial needs [1] Summary by Relevant Sections - Shareholder Information - Du Xinglian holds 2.724 million shares, accounting for 0.24% of the company's total share capital [1] - Reduction Plan - The planned reduction will occur within three months after a fifteen trading day period following the announcement [1] - The shares will be sold through centralized bidding or block trading [1] - Source of Shares - The shares being reduced were acquired prior to the company's initial public offering [1]